Sanofi SA Inhaber EO 2

€ 82,00
Opdateret 06:57:23
ISIN: FR0000120578

I dag

Market closed

Marked er lukket, åbner klokken 09:00

	26 jan	Sanofi : Sanofi and Regeneron Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

	23 jan	Sanofi : Information concerning the total number of voting rights and shares

	22 jan	Sanofi : INFORMATION REGARDING THE END OF MR. CHRISTOPHER VIEHBACHER'S TERM OF OFFICE

	22 jan	Sanofi : European Commission Grants Marketing Authorization for Cerdelga® (eliglustat), Genzyme's Oral Therapy for Gaucher Disease Type 1

	19 jan	SANOFI : Merial receives European approval for chewable NexGard® Spectra(TM)

	15 jan	Sanofi :Sanofi Enters Strategic Manufacturing Collaboration with Boehringer Ingelheim To Produce Biologics

	12 jan	Sanofi : Sanofi, Regeneron: PraluentTM (alirocumab) Marketing Authorization Application Accepted for Review by EMA

	09 jan	Sanofi : Sanofi and Regeneron Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

	19 dec	SANOFI : Information concerning the total number of voting rights and shares

	17 dec	SANOFI : Merial acquires two major equine health products from Bayer

For lav Flash Player version